Our prior studies showed that high circulating levels of osteopontin (OPN) and tissue inhibitor of metalloproteinases 1 (TIMP-1), are major predictors of kidney recovery after LTA (3, 4) in patients with kidney and liver failure. This evidence concerns the gene SPP1 and Hepatic failure.